YC S19
Sequence Bio
Discovering the true signals of disease to power life-changing drugs.
About
90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.
Founders
- Chris Gardner
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Sequence Bio.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliveryGenomicsTherapeuticsDrug discovery